scholarly journals Ledipasvir/sofosbuvir regimens for chronic hepatitis C infection: Insights from a work productivity economic model from the United States

Hepatology ◽  
2015 ◽  
Vol 61 (5) ◽  
pp. 1471-1478 ◽  
Author(s):  
Zobair M. Younossi ◽  
Yushan Jiang ◽  
Nathaniel J. Smith ◽  
Maria Stepanova ◽  
Rachel Beckerman
Keyword(s):  
United States ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Economic Model ◽  
Work Productivity ◽  
The United States ◽  
Hepatitis C Infection

Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States

2017 ◽  
Vol 20 (7) ◽  
pp. 692-702 ◽  
Author(s):  
Catherine Saint-Laurent Thibault ◽  
Divya Moorjaney ◽  
Michael L. Ganz ◽  
Bruce Sill ◽  
Shalini Hede ◽  
...  
Keyword(s):  
United States ◽  
Chronic Hepatitis ◽  
Cost Effectiveness ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
The United States ◽  
Hepatitis C Infection ◽  
Genotype 3

scholarly journals Cost-effectiveness of Screening for Chronic Hepatitis C Infection in the United States

2013 ◽  
Vol 56 (10) ◽  
pp. 1382-1393 ◽  
Author(s):  
Mark H. Eckman ◽  
Andrew H. Talal ◽  
Stuart C. Gordon ◽  
Eugene Schiff ◽  
Kenneth E. Sherman
Keyword(s):  
United States ◽  
Chronic Hepatitis ◽  
Cost Effectiveness ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
The United States ◽  
Hepatitis C Infection

Reply: Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States

2017 ◽  
Vol 20 (11) ◽  
pp. 1123-1125
Author(s):  
Catherine Saint-Laurent Thibault ◽  
Divya Moorjaney ◽  
Michael L. Ganz ◽  
Bruce Sill ◽  
Shalini Hede ◽  
...  
Keyword(s):  
United States ◽  
Chronic Hepatitis ◽  
Cost Effectiveness ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
The United States ◽  
Hepatitis C Infection ◽  
Genotype 3

scholarly journals Hepatitis C Infection: Its Sequelaie and Outcomes – State-of-the-Art Workshop, September 24 to 25, 1998

2000 ◽  
Vol 14 (suppl b) ◽  
pp. 49B-59B
Author(s):  
Association for Study of the Liver (CASL)
Keyword(s):  
United States ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Natural History ◽  
Chronic Hepatitis C ◽  
State Of The Art ◽  
The United States ◽  
Hcv Infection ◽  
Hepatitis C Infection ◽  
Consensus Statements

This report summarizes a state-of the- art workshop held in September 1998 on the “Natural History and Outcome of Hepatitis C Infection”. Sixteen Canadian and two internationally renowned hepatologists were invited. A practical classification of HCV infection served as a framework for the meeting. The concepts of modelling of chronic disease, the epidemiology of HCV infection before the introduction of anti-HCV testing, and the outcome of various forms of chronic hepatitis C in adults and children were presented. Lectures on the outcome of HCV cirrhosis, hepatocellular carcinoma, the role of liver transplantation, the influence of host factors on outcome, iron overload in chronic hepatitis C and possible modification of the natural history by antiviral therapy were followed by discussion and consensus statements pertaining to each presentation. “The European Experience in Assessing Chronic Hepatitis C” was presented by Prof G Dusheiko from the United Kingdom, and Prof Leonard Seeff from the National Institutes of Health (United States) presented “The Epidemiology and Outcome of Hepatitis C Infection in the United States and the World”.

Sign in / Sign up

Export Citation Format

Share Document